BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 24, 2012
View Archived Issues
Interim results reported from phase I/IIa ensituximab trial
Read More
PG-545 is active in several models of pancreatic cancer
Read More
GlaxoSmithKline scientists describe synthesis and preclinical testing of epelsiban
Read More
Biomarker of biliary tract carcinomas identified
Read More
Boehringer Ingelheim discloses novel 11-beta-HSD1 inhibitors
Read More
New free fatty acid FFA1 receptor agonists patented by Sanofi
Read More
Sanofi presents new casein kinase I inhibitors
Read More
La Jolla Pharmaceutical acquires rights to first-in-class galectin-3 inhibitor
Read More
Scientists at Roche prepare new GlyT-1 inhibitors
Read More
Sosei and Ceolia Pharma sign technical alliance agreement
Read More
Seikagaku launches phase II SI-614 study
Read More
FDA authorizes marketing of Quest Diagnostics test and label change for Tysabri
Read More
Chemotherapy combined with radiation shows promise in oligodendroglioma subtype
Read More
New serine/threonine-protein kinase B-raf inhibitors synthesized by Novartis
Read More
Italian company patents new muscarinic acetylcholine M3 receptor antagonists
Read More
ImmunoCellular Therapeutics provides update on phase III ICT-107 study
Read More
Treatment begins in Europe's first clinical study of hESC-derived cell therapy
Read More
Leeds University study reveals potential biomarker to monitor GIST progression
Read More
FDA extends PDUFA date for Adasuve NDA
Read More
Trius Therapeutics earns milestone payment from tedizolid collaboration
Read More
CHMP recommends updating Glivec label in Europe
Read More
Santhera regains fipamezole rights
Read More
BioAlliance Pharma advances its AMEP biotherapy
Read More
FDA approves subcutaneous Velcade
Read More
Medicure gives update on drug candidate for tardive dyskinesia
Read More